Mechanisms in Medicine: Preparing for a Paradigm Shift in Myelofibrosis Treatment

The treatment landscape for myelofibrosis (MF) continues to evolve, with several novel therapies in clinical trials displaying disease-modifying potential to alter the underlying disease biology of MF and thereby prolong survival. In part 1 of this webinar series, expert faculty will set the stage by taking a deep dive into MF pathophysiology explaining the disease-modifying potential of novel therapies and how expanded treatment goals will help achieve deeper clinical and molecular responses. Tune in to this important webinar to ensure you are at the forefront of the latest advances in MF treatment and management and get your most pressing questions answered by MF experts.